Literature DB >> 20534938

Amyloidosis of lacrimal gland.

Vinod Kumar, Neha Goel, Luke Nicholson, Jai Shankar.   

Abstract

Entities:  

Mesh:

Year:  2010        PMID: 20534938      PMCID: PMC2907051          DOI: 10.4103/0301-4738.64137

Source DB:  PubMed          Journal:  Indian J Ophthalmol        ISSN: 0301-4738            Impact factor:   1.848


× No keyword cloud information.
Dear Editor, We read with interest the article "Amyloidosis of lacrimal gland" by Prabhakaran et al.[1] We would like to congratulate the authors for this well-documented case and would like to make these observations. The authors report that approximately 24 cases of primary localized amyloidosis of orbit have been reported. However, we believe that this number is likely to be higher. In a review article by Taban et al.,[2] the authors reviewed 31 cases of primary orbital amyloidosis including one of their own. There have been a few further reports after that including a large series by Leibovitch et al.[3] The authors mention that one bilateral case of isolated lacrimal gland amyloidosis has been reported. We wish to draw attention to one of the cases reported by Cheng et al.,[4] who had bilateral isolated lacrimal gland involvement with amyloidosis. Also, Knowles et al.,[5] have described a case with serial bilateral lacrimal gland amyloidosis without systemic disease (primary localized orbital amyloidosis). This raises the total number of cases previously reported to have bilateral isolated lacrimal gland amyloidosis to at least three. Hertel's exophthalmometer is designed to measure axial proptosis and is unable to measure ocular displacement. We would value being educated as to how the authors were able to measure the displacement with the help of a Hertel's exophthalmometer. Perhaps the authors are merely implying that apart from having 2 mm of axial proptosis, the patient also had 2 mm of displacement. Lastly, was any reoccurrence noted? Recurrence has been said to occur in approximately one-third of cases as total excision is usually not possible in these patients.
  5 in total

Review 1.  Review: orbital amyloidosis.

Authors:  Mehryar Taban; Alfio Piva; Robert F See; Alfredo A Sadun; Peter A Quiros
Journal:  Ophthalmic Plast Reconstr Surg       Date:  2004-03       Impact factor: 1.746

2.  Periocular and orbital amyloidosis: clinical characteristics, management, and outcome.

Authors:  Igal Leibovitch; Dinesh Selva; Robert A Goldberg; Timothy J Sullivan; Peerooz Saeed; Garry Davis; John D McCann; Alan McNab; Jack Rootman
Journal:  Ophthalmology       Date:  2006-07-07       Impact factor: 12.079

3.  Lacrimal gland amyloidosis.

Authors:  Jacob Yen Chuan Cheng; Kee Siew Fong; Elizabeth S Cheah; C T Choo
Journal:  Ophthalmic Plast Reconstr Surg       Date:  2006 Jul-Aug       Impact factor: 1.746

4.  Amyloidosis of the orbit and adnexae.

Authors:  D M Knowles; F A Jakobiec; M Rosen; G Howard
Journal:  Surv Ophthalmol       Date:  1975 May-Jun       Impact factor: 6.048

5.  Amyloidosis of lacrimal gland.

Authors:  Venkatesh C Prabhakaran; Kalpana Babu; Anitha Mahadevan; Sowmya Raveendra Murthy
Journal:  Indian J Ophthalmol       Date:  2009 Nov-Dec       Impact factor: 1.848

  5 in total
  1 in total

1.  Amyloidosis of lacrimal gland: authors' reply.

Authors:  Sowmya Raveendra Murthy; Kalpana Babu; Anitha Mahadevan; Venkatesh C Prabhakaran
Journal:  Indian J Ophthalmol       Date:  2010 Sep-Oct       Impact factor: 1.848

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.